Alarfaj AS - Search Results

1

Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts.

Almaghlouth I, Bohuliga KG, Alanazi B, Alhawsa BK, Alabdulkareem AM, Alqarawi W, Asfina KN, Khalil N, Ali HH, Bedaiwi M, Aboabat A, Su J, Alam TA, Alanazi FG, Omair MA, Alarfaj AS, Almalag HM, Al Shamiri M, Alhabib KF. Almaghlouth I, et al. Among authors: alarfaj as. Lupus Sci Med. 2024 May 24;11(1):e001158. doi: 10.1136/lupus-2024-001158. Lupus Sci Med. 2024. PMID: 38789277 Free PMC article.

2

Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.

Alarfaj AS, Khalil N. Alarfaj AS, et al. Clin Rheumatol. 2014 Dec;33(12):1731-6. doi: 10.1007/s10067-014-2686-z. Epub 2014 Jun 4. Clin Rheumatol. 2014. PMID: 24894105

3

Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients.

Al Arfaj AS, Khalil N. Al Arfaj AS, et al. Saudi J Kidney Dis Transpl. 2023 Mar 1;34(2):154-160. doi: 10.4103/1319-2442.391894. Epub 2023 Dec 25. Saudi J Kidney Dis Transpl. 2023. PMID: 38146725 Free article.

4

Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study.

Almalag HM, Alaujan SS, Alhazzani HS, Alzamel LA, Tashkandi RS, Alarfaj HF, Alarfaj AS, Omair MA. Almalag HM, et al. Among authors: alarfaj as. Saudi Pharm J. 2022 Jul;30(7):1044-1051. doi: 10.1016/j.jsps.2022.04.008. Epub 2022 Apr 19. Saudi Pharm J. 2022. PMID: 35903531 Free PMC article.

5

ANCA associated vasculitis in patients from Saudi Arabia.

Al Arfaj AS, Khalil N. Al Arfaj AS, et al. Pak J Med Sci. 2018 Jan-Feb;34(1):88-93. doi: 10.12669/pjms.341.13881. Pak J Med Sci. 2018. PMID: 29643885 Free PMC article.

6

Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study.

Almalag HM, Almuhareb AM, Alsharafi AA, Alhawassi TM, Alghamdi AA, Alarfaj H, Omair MA, Alomari BA, Alblowi MS, Abouzaid HH, Alarfaj AS. Almalag HM, et al. Among authors: alarfaj as. Saudi Pharm J. 2021 May;29(5):462-466. doi: 10.1016/j.jsps.2021.04.009. Epub 2021 Apr 23. Saudi Pharm J. 2021. PMID: 34135672 Free PMC article.

7

The Patient Activation Measure in Patients with Rheumatoid Arthritis: A Systematic Review and Cross-Sectional Interview-Based Survey.

Al Juffali L, Almalag HM, Alswyan N, Almutairi J, Alsanea D, Alarfaj HF, Alarfaj AS, Abouzaid HH, Omair MA. Al Juffali L, et al. Among authors: alarfaj as. Patient Prefer Adherence. 2022 Oct 19;16:2845-2865. doi: 10.2147/PPA.S379197. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 36303596 Free PMC article.

8

An eosinophilic variant granulomatosis with polyangiitis involving the dura, bilateral orbits, and mastoids.

Al-Hakami H, Al-Arfaj AS, Al-Sohaibani M, Khalil NA. Al-Hakami H, et al. Saudi Med J. 2016 Jun;37(6):690-3. doi: 10.15537/Smj.2016.6.14718. Saudi Med J. 2016. PMID: 27279517 Free PMC article.

9

Prevalence of systemic lupus erythematosus in central Saudi Arabia.

Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM, Sekeit MA. Al-Arfaj AS, et al. Saudi Med J. 2002 Jan;23(1):87-9. Saudi Med J. 2002. PMID: 11938371

10

Knee osteoarthritis in Al-Qaseem, Saudi Arabia.

Al-Arfaj AS, Alballa SR, Al-Saleh SS, Al-Dalaan AM, Bahabry SA, Mousa MA, Al-Sekeit MA. Al-Arfaj AS, et al. Saudi Med J. 2003 Mar;24(3):291-3. Saudi Med J. 2003. PMID: 12704507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters